These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15319026)

  • 21. [Risperidone in the treatment of psychotic disorders associated with mental retardation].
    Franco MA; Herraiz M; Martínez MJ; Fernández MC; Conde V
    Actas Esp Psiquiatr; 2000; 28(4):251-6. PubMed ID: 11116796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone-induced obsessive-compulsive symptoms in two children.
    Diler RS; Yolga A; Avci A; Scahill L
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S89-92. PubMed ID: 12880504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
    van der Feltz-Cornelis CM; Aldenkamp AP
    Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy, psychosis and clozapine.
    Langosch JM; Trimble MR
    Hum Psychopharmacol; 2002 Mar; 17(2):115-9. PubMed ID: 12404701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study.
    Troost PW; Althaus M; Lahuis BE; Buitelaar JK; Minderaa RB; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):561-73. PubMed ID: 17069545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting risperidone improves negative symptoms in stable psychotic patients.
    Curtis VA; Katsafouros K; Möller HJ; Medori R; Sacchetti E
    J Psychopharmacol; 2008 May; 22(3):254-61. PubMed ID: 18308804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open trial of risperidone in 24 young children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperprolactinemia in a child diagnosed with Asperger syndrome and hyperkinetic disorder treated with risperidone].
    Monge Galindo L; Escosa García L; García Sánchez N; Ruiz-Lázaro PM
    An Pediatr (Barc); 2009 Jul; 71(1):86-7. PubMed ID: 19473900
    [No Abstract]   [Full Text] [Related]  

  • 32. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
    Saxena K; Chang K; Steiner H
    Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus.
    Stern AP; Trieu ML
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):403-4. PubMed ID: 23083030
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings.
    Barterian JA; Arnold LE; Brown NV; Farmer CA; Williams C; Findling RL; Kolko DJ; Bukstein OG; Molina BSG; Townsend L; Aman MG
    J Am Acad Child Adolesc Psychiatry; 2017 Dec; 56(12):1026-1033. PubMed ID: 29173736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using risperidone for Alzheimer's dementia-associated psychosis.
    McNeal KM; Meyer RP; Lukacs K; Senseney A; Mintzer J
    Expert Opin Pharmacother; 2008 Oct; 9(14):2537-43. PubMed ID: 18778191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidone.
    Silver H; Aharon N; Schwartz M
    J Clin Psychopharmacol; 2000 Feb; 20(1):112-4. PubMed ID: 10653224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.